Erratum: Antifibrotic effects of protocatechuic aldehyde on experimental liver fibrosis (Pharmaceutical Biology (2012) 50: 4 (413-419) DOI: 10.3109/13880209.2011.608193);Antifibrotic effects of protocatechuic aldehyde on experimental liver fibrosis

Pharmaceutical Biology

Volumn 50, Issue 4, 2012, Pages 413-419

  Li, Chunmei ^a   Jiang, Wanglin ^a,b   Zhu, Haibo ^b   Hou, Jian ^b  

^a YANTAI UNIVERSITY   (China)

^b Luye Pharma Group Ltd   (China)

Author keywords

Connective transforming growth factor; Liver fibrosis; Protocatechuic aldehyde; Transforming growth factor 1

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CONNECTIVE TISSUE GROWTH FACTOR; HYALURONIC ACID; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; PROTOCATECHUALDEHYDE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFIBROTIC ACTIVITY; ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIVER FIBROSIS; MALE; NONHUMAN; PROTEIN DEFECT; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS INHIBITION; RAT; UPREGULATION; WESTERN BLOTTING;

RATTUS;

EID: 84863234386     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2013.782159     Document Type: Erratum

References (28)

1. Bataller R, Brenner DA. (2005). Liver fbrosis. J Clin Invest, 115, 209-218.
2. Blom IE, Goldschmeding R, Leask A. (2002). Gene regulation of connective tissue growth factor: new targets for anti-fbrotic therapy. Matrix Biol, 21, 473-482. (Pubitemid 35248272)
3. Bosetti C, Levi F, Lucchini F, Zatonski WA, Negri E, La Vecchia C. (2007). Worldwide mortality from cirrhosis: An update to 2002. J Hepatol, 46, 827-839. (Pubitemid 46529045)
4. China Medical Association Infectious Branch. (1995). The standard of grading and staging of viral hepatitis. Zhonghua Chuanranbing Zazhi, 13, 241-247.
5. George J, Tsutsumi M. (2007). siRNA-mediated knockdown of connective tissue growth factor prevents N-nitrosodimethylamine-induced hepatic fbrosis in rats. Gene Ter, 14, 790-803. (Pubitemid 46706059)
6. Gressner AM, Weiskirchen R, Breitkopf K, Dooley S. (2002). Roles of TGF-beta in hepatic fbrosis. Front Biosci, 7, 793-807.
7. Gressner AM, Weiskirchen R. (2003). The tightrope of therapeutic suppression of active transforming growth factor-β: High enough to fall deeply? J Hepatol, 39, 856-859. (Pubitemid 37372198)
8. Gressner OA, Gressner AM. (2008). Connective tissue growth factor: A fbrogenic master switch in fbrotic liver diseases. Liver Int, 28, 1065-1079.
9. Gressner OA, Lahme B, Rehbein K, Siluschek M, Weiskirchen R, Gressner AM. (2008). Pharmacological application of cafeine inhibits TGF-beta-stimulated connective tissue growth factor expression in hepatocytes via PPARgamma and SMAD2/3-dependent pathways. J Hepatol, 49, 758-767.
10. Grifths C, Rooney C, Brock A. (2005). Leading causes of death in England and Wales-how should we group causes? Health Stat Q, 28, 6-17.
11. Han CJ, Lin R, Liu JT, Liu Y, Zhang H. (2007). Protection of vascular endothelial cells from ox-LDL induced injury by protocatechualdehyde. Zhong Yao Cai, 30, 1541-1544.
12. Hayasaka A, Saisho H. (1998). Serum markers as tools to monitor liver fbrosis. Digestion, 59, 381-384. (Pubitemid 28360697)
13. Kim KJ, Kim MA, Jung JH. (2008). Antitumor and antioxidant activity of protocatechualdehyde produced from Streptomyces lincolnensis M-20. Arch Pharm Res, 31, 1572-1577.
14. Kim YS, Kim NH, Lee SW, Lee YM, Jang DS, Kim JS. (2007). Effect of protocatechualdehyde on receptor for advanced glycation end products and TGF-beta1 expression in human lens epithelial cells cultured under diabetic conditions and on lens opacity in streptozotocin-diabetic rats. Eur J Pharmacol, 569, 171-179. (Pubitemid 47198248)
15. Körner T, Kropf J, Gressner AM. (1996). Serum laminin and hyaluronan in liver cirrhosis: markers of progression with high prognostic value. J Hepatol, 25, 684-688. (Pubitemid 26373886)
16. Lee MK, Ha NR, Yang H, Sung SH, Kim GH, Kim YC. (2008). Antiproliferative activity of triterpenoids from Eclipta prostrata on hepatic stellate cells. Phytomedicine, 15, 775-780.
17. Li G, Li D, Xie Q, Shi Y, Jiang S, Jin Y. (2008). RNA interfering connective tissue growth factor prevents rat hepatic stellate cell activation and extracellular matrix production. J Gene Med, 10,1039-1047.
18. Li G, Xie Q, Shi Y, Li D, Zhang M, Jiang S, Zhou H, Lu H, Jin Y. (2006). Inhibition of connective tissue growth factor by siRNA prevents liver fbrosis in rats. J Gene Med, 8, 889-900. (Pubitemid 44097143)
19. Li GS, Jiang WL, Tian JW, Qu GW, Zhu HB, Fu FH. (2010). In vitro and in vivo antifbrotic effects of rosmarinic acid on experimental liver fbrosis. Phytomedicine, 17, 282-288.
20. Liu X, Hu H, Yin JQ. (2006). Terapeutic strategies against TGF-beta signaling pathway in hepatic fbrosis. Liver Int, 26, 8-22.
21. Lv T, Yao XX. (2006). Comparison of protocatechuic aldchyde in Radix Salvia miltiorrhiza and corresponding pharmacologicalsera from normal and fbrotic rats by high performance liquid chromatography. World J Gastroenterol, 12, 2195-2200.
22. Murawaki Y, Ikuta Y, Koda M, Nishimura Y, Kawasaki H. (1996). Clinical signifcance of serum hyaluronan in patients with chronic viral liver disease. J Gastroenterol Hepatol, 11, 459-465. (Pubitemid 26151921)
23. Mi KL, Na RH, Hyekyung Y, Sang HS, Gun HK, Young CK. (2008). Anti-proliferative activity of triterpenoids from Eclipta prostrata on hepatic stellate cells. Phytomedicine, 15, 775-780.
24. Paradis V, Dargere D, Bonvoust F, Vidaud M, Segarini P, Bedossa P. (2002). Effects and regulation of connective tissue growth factor on hepatic stellate cells. Lab Invest, 82, 767-774.
25. Tsukada S, Parsons CJ, Rippe RA. (2006). Mechanisms of liver fbrosis. Clin Chim Acta, 364, 33-60.
26. Uchio K, Graham M, Dean NM, Rosenbaum J, Desmoulière A. (2004). Down-regulation of connective tissue growth factor and type I collagen mRNA expression by connective tissue growth factor antisense oligonucleotide during experimental liver fbrosis. Wound Repair Regen, 12, 60-66. (Pubitemid 38249137)
27. Zhou Z, Liu Y, Miao AD, Wang SQ. (2005). Protocatechuic aldehyde suppresses TNF-α-induced ICAM-1 and VCAM-1 expression in human umbilical vein endothelial cells. Eur J Pharmacol, 513, 1-8. (Pubitemid 40692242)
28. Zhou Z, Zhang Y, Ding XR, Chen SH, Yang J, Wang XJ, Jia GL, Chen HS, Bo XC, Wang SQ. (2007). Protocatechuic aldehyde inhibits hepatitis B virus replication both in vitro and in vivo. Antiviral Res, 74, 59-64. (Pubitemid 46366009)